Mitchell Dean J

Mitchell Dean J is listed in filings as Director at Theravance Biopharma, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2026, including 8 public disclosures. Recent filings connect the profile to Theravance Biopharma, Inc. (TBPH) and Praxis Precision Medicines, Inc. (PRAX). The current snapshot covers public activity from May 21, 2025 to Jun 16, 2026. Reported amounts are shown as $222.9K to $463.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.